Adherence to COVID-19 vaccines in cancer patients: promote it and make it happen!

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

1. Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review.Annals of oncology : official journal of the European Society for Medical Oncology · 2022
   Pooled it
2. Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine.Journal of the National Comprehensive Cancer Network : JNCCN · 2022
   Observational
3. SARS-CoV-2 spike protein inhibits growth of prostate cancer: a potential role of the COVID-19 vaccine killing two birds with one stone.Medical oncology (Northwood, London, England) · 2022
   Article
4. COVID-19 Vaccine Hesitancy among Patients with Inflammatory Bowel Disease Receiving Biologic Therapies in Kuwait: A Cross-Sectional Study.Vaccines · 2021
   Article
5. Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis.European journal of cancer (Oxford, England : 1990) · 2021
   Review
6. COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in Italy.European journal of cancer (Oxford, England : 1990) · 2021
   Observational
7. Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix.European journal of cancer (Oxford, England : 1990) · 2021
   Article
8. The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience.European journal of cancer (Oxford, England : 1990) · 2021
   Article
9. Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer.European journal of cancer (Oxford, England : 1990) · 2021
   Review

Corrections and comments

• Comment on
  The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.2021

Authors and funding

2 authors at 2 institutions in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as